| Trial ID: | L0270 |
| Source ID: | NCT02163954
|
| Associated Drug: |
Ticagrelor
|
| Title: |
ONSET and OFFSET of Ticagrelor in ESRD
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Ticagrelor|DRUG: Clopidogrel
|
| Outcome Measures: |
Primary: The difference of antiplatelet effects assessed by VerifyNow assay, The difference of PRU values achieved following antiplatelet therapy, 14 days after study drug treatment | Secondary: the rate of onset and offset of the antiplatelet effects, the difference of slope during onset and offset of study drugs, 14 days after study drugs treatment | Other: Adverse events, Adverse events such as bleeding, during study period
|
| Sponsor/Collaborators: |
Sponsor: Kyunghee University Medical Center | Collaborators: Kyunghee University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
16
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2013-01
|
| Completion Date: |
2013-08
|
| Results First Posted: |
|
| Last Update Posted: |
2014-06-16
|
| Locations: |
Kyung Hee University Hospital, Seoul, 130-702, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02163954
|
